Literature DB >> 19280715

Predisposition to idiopathic thrombocytopenic purpura maps close to the major histocompatibility complex class I chain-related gene A.

Maria Helena Thomaz Maia1, Raquel de Lima Peixoto, Clayton Pereira Silva de Lima, Milena Magalhães, Leonardo Sena, Perpétua do Socorro Silva Costa, Fabíola Brasil Barbosa, Layanna Freitas de Oliveira, Matilde Romero, Christina Nogueira de Araujo Silva, Eduardo José Melo dos Santos.   

Abstract

Idiopathic thrombocytopenic purpura (ITP) is an autoimmune condition with poorly known etiology, characterized by platelet destruction. Genetic association studies of this disease are scarce, discrepant, and restricted to major histocompatibility complex (MHC) polymorphisms. Hence, a case-control study was conducted with an aim to map the MHC to IPT susceptibility using HLA-B and nine microsatellite loci encompassing MHC class I, II, and III regions. We compared the allelic frequencies in samples of unrelated healthy controls and ITP patients. After correction for multiple tests, only allele MICA*183, also known as A5.1, demonstrated an association, resulting in the identification of a major predisposing region close to STR-MICA. This result may highlight the putative functional role of MICA in the immune response to ITP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280715     DOI: 10.1016/j.humimm.2009.01.011

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia.

Authors:  Lili Ji; Yanxia Zhan; Boting Wu; Pu Chen; Luya Cheng; Yang Ke; Xibing Zhuang; Fanli Hua; Lihua Sun; Hao Chen; Feng Li; Yunfeng Cheng
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

Review 2.  Emerging Concepts in Immune Thrombocytopenia.

Authors:  Maurice Swinkels; Maaike Rijkers; Jan Voorberg; Gestur Vidarsson; Frank W G Leebeek; A J Gerard Jansen
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.